We served as appellate counsel for the plaintiff in an appeal involving a products liability lawsuit brought against a generic drug manufacturer and distributor that asserted federal conflict preemption defenses at the pleading stage. The Appellate Court answered the certified questions and rejected the defendants’ federal preemption defenses. This case was one of the first in the United States (federal and state courts) to reject a federal preemption defense raised by a generic drug manufacturer. Guvenoz v. Target Corporation and Teva Pharmaceuticals USA, Inc., 2015 IL App (1st) 133940, pet. for leave to appeal denied, No. 119226 (Sept. 30, 2015); cert. denied, 136 S. Ct. 2409 (2016).
We served as appellate counsel for the plaintiff-appellee in this case, which is now a leading products liability case involving a medical device and the duty to warn. Plaintiff’s $16 million verdict was affirmed. Hansen v. Baxter, 198 Ill. 2d 420 (2002), 309 Ill. App. 3d 869 (1st Dist. 1999).